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Reliability of chronic allograft nephropathy diagnosis in sedifferent renal compartments [3] . Histological confirmaquential protocol biopsies.
tion of CAN in patients with slowly deteriorating renal
Background. Chronic allograft nephropathy (CAN) progfunction usually shows that the degree of renal scarring resses rapidly during the first few months and slowly thereafter.
is advanced, probably beyond the threshold of reversibilAlthough the presence of CAN in protocol renal biopsies is a ity. Accordingly, it seems unreasonable to expect that predictor of outcome, the reliability of this diagnosis according to Banff criteria has not been characterized.
at this stage of scarring a therapeutic maneuver may
Methods. Renal lesions were evaluated according to the significantly slow renal function deterioration [4] .
Banff criteria in sequential protocol biopsies performed at 4 Some centers have performed protocol biopsies as an and 14 months in 310 biopsies obtained from 155 patients. attempt to diagnose CAN at an earlier stage. In these
Results. CAN progressed from 40 to 53% (P ϭ 0.001) while studies, the timing of histological evaluation has been serum creatinine remained stable (146 Ϯ 44 vs. 147 Ϯ 48 mol/L, P ϭ NS). Graft survival in patients with and without targeted during the first two years after transplant. Nev-CAN in the first biopsy was 74 versus 91% (P Ͻ 0.05), and in ertheless, CAN was a frequent finding in all of the studthe second biopsy 75 versus 94% (P Ͻ 0.05). In 54 patients ies, ranging between 25 and 70% [5] [6] [7] [8] [9] . In studies of (35%) no CAN was present in both biopsies, 39 (25%) showed sequential protocol biopsies it has been observed that progression to CAN, 19 (12%) showed regression of CAN, the incidence and severity of CAN is time dependent and 43 (28%) showed CAN in both biopsies. Graft survival was: 100%, 81.6%, 82.6% and 69.4%, respectively (P Ͻ 0.01). [10] [11] [12] [13] [14] . Furthermore, in all of the previously mentioned Assuming that CAN does not regress and sampling error is studies there is agreement that the presence of CAN in normally distributed, we estimated that 25% of biopsies cannot stable grafts is an independent predictor of renal allograft be properly classified.
outcome. Taken together, these results suggest that the Conclusions. The increase in the incidence of CAN between presence of scarring in protocol biopsies could be considthe 4 th and 14 th month is lower than the proportion of misclassified biopsies. Thus, monitoring the progression of CAN by ered as a primary efficacy variable in a hypothetical clinimeans of two sequential biopsies at 4 and 14 months is inaccucal trial aimed to prevent CAN [15, 16] . However, neither rate. We suggest that progression of scarring be monitored by the accuracy of the diagnosis of CAN in sequential protomeans of a donor and a protocol biopsy performed during the col biopsies nor the ideal timing of biopsies to detect first year evaluated with a quantitative approach.
patients at risk of graft failure have been properly evaluated.
The present study analyzed the evolution of renal leChronic allograft nephropathy (CAN) is the most sions evaluated according to the Banff schema in two common cause of late renal allograft failure [1] clinically sequential protocol biopsies performed at 4 th and 14 th characterized by a slow deterioration of renal function months after transplantation. [2] . Histologically, CAN is defined according to the Banff schema, a classification system that relies on the semiquantitative evaluation of chronic renal damage in the METHODS Ͻ1 g/24 h; and (c) stable renal function, defined as variembedded in paraffin, cut into 4-m sections and stained ability of serum creatinine of less than 15% during two with hematoxylin and eosin, periodic acid-Schiff, Masweeks before and after biopsy. A second protocol biopsy son's trichrome and silver methenamine. Renal lesions was performed at approximately one year of follow-up were graded and diagnosed according to the 1997 Banff regardless of serum creatinine or proteinuria. For the schema by two observers in the absence of any clinical present study, only patients biopsied until December information [3] . Protocol biopsies were not available to 1996 were included.
clinicians and consequently were not employed to make any clinical decisions.
Definition of clinical variables
Statistics The following variables were evaluated in each patient at the time of surgery: donor type (heart beating or
Results are expressed as the mean Ϯ standard devianon-heart beating), age and sex of the donor and the tion. Table 1 . as an acute rise of serum creatinine Ͼ30% that responded to antirejection therapy. A diagnostic biopsy at Biopsies and sampling adequacy the time of serum creatinine worsening was done in 75%
The first biopsy was performed at approximately 4 of patients. Hypertension before and after transplantamonths (113 Ϯ 46 days) and the second biopsy was done tion was defined as a mean arterial pressure Ͼ107 mm Hg just after the first year (435 Ϯ 70 days). Mean number (blood pressure of ϳ140/90 mm Hg) and/or the requireof glomeruli was 12 Ϯ 7 and 11 Ϯ 7, respectively. All ment of antihypertensive drugs. During this period of biopsies contained at least one glomerular and one artetime, different combinations of immunosuppressive rial section and sample size distribution according to drugs have been employed: (a) CsA and prednisone (N ϭ 1997 Banff criteria in the 310 biopsies was: 173 (55.8%) 10), (b) concomitant induction therapy with antilymphobiopsies were adequate (Ն10 glomeruli, Ն2 arteries), 72 cytic antibodies, CsA and prednisone (N ϭ 87); (c) triple (23.2%) biopsies represented minimum sample adestandard regimen with CsA, azathioprine and predniquacy (between 7 and 9 glomeruli and at least one artesone (N ϭ 18); (d) triple regimen with CsA, mycophenorial section) and 65 (21.0%) biopsies were inadequate late mofetil and prednisone (N ϭ 35); and (e) induction (between 1 and 6 glomeruli and at least one arterial therapy with antilymphocytic antibodies, mycophenolate section). mofetil and prednisone (N ϭ 5) [15] .
Temporal evolution of renal lesions Biopsies
During this period of time no significant modification Biopsies were performed and processed for routine light microscopy as previously described [7] . Tissue was in the intensity of acute lesions was observed while the Abbreviations are: HBD, heart-beating donor; NHBD, non-heart beating donor; HCV, hepatitis C virus antibodies; APKD, adult polycystic kidney disease; PRA, panel reactive antibodies.
correlation was found between the degree of acute le- and CAN associated with acute rejection (N ϭ 4). Histological diagnoses in the second protocol biopsy were: normal (N ϭ 64), borderline (N ϭ 8), acute rejection (N ϭ 1), CAN (N ϭ 53), CAN associated with borderline severity of chronic lesions increased in all renal compartchanges (N ϭ 28), and CAN associated with acute rejecments (Table 2 ). Despite progression of renal scarring, tion (N ϭ 1). Thus, in the first protocol biopsy CAN was serum creatinine and calculated GFR as well as mean diagnosed in 62 of 155 (40.0%) patients and in the second arterial pressure at the time of the first and second protoprotocol biopsy in 82 of 155 (52.9%) patients (P ϭ 0.001). col biopsies remained unchanged. A significant but slight Not only the proportion but also the severity of CAN increase of proteinuria was observed. According to usual increased in the second biopsy. Grading of CAN in the clinical practice, CsA doses and CsA levels were lower at the time of the second protocol biopsy (Table 3) .
first was: absent in 93 (60.0%) patients, mild in 53 (34.2%), moderate in 9 (5.8%), and no cases showed To study the degree of correlation between Banff scores in the first and second biopsies, a matrix correlasevere CAN. In the second biopsy CAN was: absent in 73 (47.1%), mild in 54 (34.8%), moderate in 27 (17.4%), tion between Banff scores in both biopsies was built. The following significant positive correlations were oband severe in 1 (0.6%; P ϭ 0.01). A 2 ϫ 2 contingency table in which the histological served: g-score in the first and second biopsy (rho ϭ 0.20, P ϭ 0.01), i-score in the first and second biopsy diagnosis was summarized as presence or absence of CAN was employed to study the concordance of the (rho ϭ 0.31, P ϭ 0.001), ah-score in the first and second biopsy (rho ϭ 0.18, P ϭ 0.03), ci-score in the first and diagnosis of CAN in both biopsies (Table 4 ). In 97 patients (62.5%) there was agreement in the diagnosis obsecond biopsy (r ϭ 0.30, P ϭ 0.0002) and ct-score in the first and second biopsy (rho ϭ 0.28, P ϭ 0.004). No tained in both sequential biopsies. In 39 patients (25.2%) dose until the first biopsy and between biopsies was similar in both groups ( at the time of the first biopsy. the second biopsy is due to inadequate sampling, the concordance of the diagnosis of CAN was studied in Prediction of graft survival patients with at least 7 glomeruli (minimum sample adeIn order to study which timing of protocol biopsy alquacy) in both biopsies and in patients with at least one lowed a better prediction of outcome, graft survival acbiopsy containing Ͻ7 glomeruli (inadequate sample). As cording to the presence or absence of CAN in the first shown in Table 5 , evolution of CAN was not different and second protocol biopsies was studied separately by in both groups.
means of Kaplan-Meier analysis. Graft survival in paConcordance of the diagnosis of CAN and outcome tients with and without CAN was 74 and 91% in the first biopsy (P Ͻ 0.05) and 75 and 94% in the second biopsy To evaluate whether apparent regression of CAN in (P Ͻ 0.05). a proportion of patients represents the inaccuracy of the diagnostic criteria or a real regression of chronic lesions, serum creatinine, proteinuria at the time of first and DISCUSSION second protocol biopsies and renal allograft survival
The present study shows that chronic renal allograft were compared in the four previously mentioned groups.
lesions progress between the 4 th and 14 th month, while As shown in Table 6 , serum creatinine and proteinuria serum creatinine, calculated GFR and arterial pressure values were low in patients not displaying CAN in both remain stable. The only clinical modification between the biopsies, intermediate in patients showing either protwo protocol biopsies was a slight increase of proteinuria gression or regression of CAN and high in patients diagthat, despite reaching statistical significance, was too nosed of CAN in both biopsies. Similarly, renal allograft small to be considered of any clinical relevance. During survival was excellent in patients without CAN, intermethis period of time, the CsA dose was tapered and accorddiate in patients in whom CAN apparently progressed ingly CsA levels decreased. This modification may partly or regressed, and poor in patients displaying CAN in explain the lack of deterioration in renal function despite both biopsies (Table 6 ). Despite patients who progressed the progression of renal scarring [18] . Together these and patients who regressed showed a similar clinical evoresults point out that the correlation between histological lution, the probability to progress was higher than the damage and clinical parameters in transplanted patients probability to regress (25% vs. 12%, P Ͻ 0.05).
is not good enough to consider either renal function or Clinical and histological variables associated with the proteinuria as a reliable marker of the progression of progression of CAN CAN [6, 7, 15] . This observation reinforces the notion that protocol biopsies allow information to be obtained Patients were classified as progression or no progression of CAN. Progression of CAN was defined as the that is not contained in clinical data. Cyclosporine (CsA) levels (ng/mL) were determined in 102 and 48 patients in the no progression of CAN and progression of CAN groups, respectively, since five patients did not receive cyclosporine.
The severity of acute and chronic lesions observed in variability could account for some of these differences [22] . a renal compartment in the first biopsy correlated with the same type of lesion in the same compartment in In a subset of patients diagnosed of CAN at four months no chronic lesions were observed in the one-year the second biopsy. In contrast with the progression of chronic lesions, acute lesions remained stable. In sequenbiopsy. This result raises the question whether apparent regression of CAN reflects sampling error, intraobserver tial protocol biopsies, Rush, Jeffery and Gough [10] and Legendre et al [12] observed that acute lesions peak variability or a real regression of chronic damage. The present study's biopsies were evaluated according to during the first few months and decrease thereafter, while chronic lesions progress during the first year. In Banff criteria, which have been devised to evaluate diagnostic but not protocol biopsies. Despite that CAN repcontrast, Nankivell et al showed that acute lesions peak at three months while chronic lesions remain stable durresents a continuum, according to the Banff schema it is diagnosed when tubular atrophy is present and interstiing the first year [19] . We previously observed that the number of interstitial infiltrating cells assessed with tial fibrosis is observed in more than 5% of the biopsy [3] . The extension of interstitial fibrosis and tubular atromonoclonal antibodies decreased during the first year, while acute lesions assessed with an ordinal scale apparphy is used to grade CAN as mild (up to 25%), moderate (26-50%) and severe (Ͼ50%). In such a grading system, ently remained stable [20] . We did not find any correlation between acute lesions in the early biopsy and chronic intra-and interobserver variability increases as the extension of damage approaches the cut-off separating two lesions in the second one, in contrast to other reports [10, 14, 19, 21] . It is difficult to find a reasonable explanacategories. In the present study, the majority of patients displayed either no CAN or grade I CAN. Accordingly, tion for these differences, but the timing of biopsies, patient characteristics and immunosuppression were not in a proportion of biopsies, the degree of chronic damage should have been in the cut-off separating both categothe same in the different centers. Also, inter-observer ries. This notion is reinforced by the observation that was heterogeneous in the studied set of patients, but graft survival was low in patients displaying CAN in both raises concern about a possible detrimental effect of low biopsies, excellent in patients not displaying CAN in any cyclosporine levels during the first year [23] . biopsy, and intermediate in patients with progression or According to Banff schema an adequate sample must regression of CAN. We interpret that in patients discontain at least ten glomeruli and two arteries. This conplaying CAN in both biopsies, the degree of interstitial dition has been defined to properly diagnose acute rejecfibrosis and tubular atrophy was clearly over the threshtion but not CAN, since the distribution of acute lesions old of 5% and in patients not displaying CAN in both is rather variable [3] . No relationship could be estabbiopsies, no chronic lesions were present at all. In palished between biopsy adequacy and the frequency distritients with either apparent progression or regression, bution of the diagnosis of CAN, suggesting that the samthe degree of chronic lesions was around the cut-off ple size requirement for a diagnosis of CAN may be less separating CAN from no CAN, and accordingly the than for acute rejection. This observation suggests that probability to misclassify such a pair of biopsies was the even small samples can be considered viable to evaluate highest.
the extension of chronic tubulointerstitial damage, espeProgression of CAN was observed in 25% of patients cially if they are evaluated by means of quantitative while regression was observed only in 12%, confirming measures [11, 16, [24] [25] [26] . that the probability to progress was higher than the probThe incidence of CAN progressed from 40 to 53% ability to regress. Approximately half of the patients who during the study period in the overall group. This inprogressed displayed CAN grade II or III in the second crease is relatively moderate if we take into consideration biopsy while the other half displayed CAN grade I. Nearly all patients with apparent regression displayed that the incidence of lesions that mimic CAN in blindly CAN grade I in the first biopsy. Accordingly, this result evaluated donor biopsies at our center is 15% [15] . Thus, suggests that apparent regression reflects the difficulty renal allograft scarring progresses rapidly during the first to properly classify biopsies with mild interstitial fibrosis few months and slowly thereafter. This observation may and tubular atrophy.
have important implications in the design of trials aimed The present data allow an evaluation of the accuracy to prevent renal scarring. In a trial in which progression of Banff criteria to diagnose CAN in protocol biopsies. of scarring is evaluated by means of two sequential biopIf we assume that during the study period real regression sies, the ideal timing of biopsies to reduce sample size of scarring has not occurred, then 12% of the patients requirements will be defined according to the shortest with apparent regression of CAN were misclassified. A follow-up period in which the highest progression occurs. similar proportion of patients with progression to CAN The present data do not favor the utilization of two must also have been misclassified if we assume that the protocol biopsies done during the first year, but suggest distribution of sampling error follows a normal distributhat the best strategy to monitor progression of chronic tion. Thus, in our hands the evaluation of protocol bioplesions is to perform a donor and a protocol biopsy dursies with Banff criteria implies a misclassification of aping the first year [15, 16] . proximately 25% of the cases. This number represents In summary, only a moderate increase in the incidence both sampling error associated with the performance of and severity of CAN occurs between the 4 and 14 month. two sequential biopsies and intraobserver variability.
Despite the estimated error of 25% in the diagnosis of Moreover, in approximately 25% of biopsies the diagno-CAN, we studied which clinical variables and histological sis of CAN is misclassified. Taken together, these data lesions in the first biopsy were associated with the prosuggest that evaluation of two sequential biopsies by gression of CAN. Patients displaying less severe chronic means of the Banff schema is not the ideal strategy to lesions at four months had a higher probability to promonitor progression of renal scarring. Thus, we suggest gress. This result is probably a consequence of the gradmonitoring the progression of scarring by means of a ing system employed. Mild progression of fibrosis in padonor and a protocol biopsy performed during the first tients not displaying CAN in the first biopsy (interstitial year and evaluated with a quantitative approach. fibrosis in less than 5% of biopsy surface) will result in progression to CAN. On the contrary, in patients already ACKNOWLEDGMENTS displaying CAN grade I (interstitial fibrosis affecting 6 to 25%) mild progression of interstitial fibrosis, for example 
